Do you want to read an article? Please log in or register.
Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
United European Gastroenterol J.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A
doi: 10.1177/2050640620929133.
Inflammatory Bowel Disease
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
Lancet Gastroenterol Hepatol.
Iacucci M, Cannatelli R, Labarile N, Mao R, Panaccione R, Danese S, Kochhar GS, Ghosh S, Shen B
doi: 10.1016/S2468-1253(20)30119-9.
COMMENTED
Inflammatory Bowel Disease
Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology.
Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD
doi: 10.1053/j.gastro.2020.05.032.
Inflammatory Bowel Disease
Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis
United European Gastroenterol J
Singh AK, Jena A, Kumar-M P, Sharma V, Sebastian S
doi: 10.1177/2050640620972602
Inflammatory Bowel Disease
Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey
Inflamm Bowel Dis.
Martin Arranz E, Suarez Ferrer C, García Ramírez L, Rueda García JL, Sánchez-Azofra M, Poza Cordón J, Noci J, Zabana Y, Barreiro-de Acosta M, Martín-Arranz MD
doi: 10.1093/ibd/izaa142.
Inflammatory Bowel Disease
Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic
J Crohns Colitis.
Reinisch W, Danese S, Peyrin-Biroulet L, Loftus EV
doi: 10.1093/ecco-jcc/jjaa119.
Inflammatory Bowel Disease
Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts
Clin Gastroenterol Hepatol.
Allocca M, Fiorino G, Zallot C, Furfaro F, Gilardi D, Radice S, Danese S, Peyrin-Biroulet L
doi: 10.1016/j.cgh.2020.04.071.
Inflammatory Bowel Disease
Risk of bacteremia in hospitalised patients with inflammatory bowel disease: a 9-year cohort study
United European Gastroenterol J.
Goren I, Brom A, Yanai H, Dagan A, Segal G, Israel A
doi: 10.1177/2050640619874524.
Inflammatory Bowel Disease
Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey
No abstract available